
Renewed Partnership Set to Boost Discovery of New Medicines
Research and development into new drug treatments is set to benefit from closer collaboration between the University of Exeter and Medicines Discovery Catapult (MDC).
Category

Research and development into new drug treatments is set to benefit from closer collaboration between the University of Exeter and Medicines Discovery Catapult (MDC).

Researchers at the Living Systems Institute are using viruses to fight bacteria, as the threat of antimicrobial resistance grows

Dr Ben Temperton, Associate Professor of Microbiology at the University of Exeter, has set up the Citizen Phage Library, in collaboration with PhageDirectory and Exeter Science Centre.

A University of Exeter research group has helped to eliminate tonnes of plastic waste entering the sea, improving the health of organisms and the environment.

Scientists at the MRC Centre for Medical Mycology made a discovery that could help in the fight against a fungus that kills around 200,000 people every year and causes lung and allergic diseases in millions of others.

Researchers at the MRC Centre for Medical Mycology discover that faulty signalling in the immune system of healthy individuals leads to Chromoblastomycosis.

Professor Mike Allen and the PhycoMExUK team are using innovative technologies and hydrothermal processes to turn seaweed biomass into sustainable fertilisers and biofuels.

Research conducted by Dr Anne Leonard and Professor Will Gaze at the University of Exeter has shaped the global understanding of antimicrobial resistance (AMR), and has influenced government and WHO strategies in tackling one of the world’s biggest environmental threats.

Research conducted by the University of Exeter Medical School, the University of Hong Kong, and pharmaceutical company AstraZeneca revealed that low concentrations of antibiotics in the environment could be contributing to the evolution of antibiotic resistance.

Behind the paper “Bacterial biodiversity drives the evolution of CRISPR-based phage resistance” – or, evolution is complicated.

From streams and lakes, to rivers and oceans, antibiotics are making their way into our waters in ever greater concentrations, increasing antibiotic resistance and risking a rise in deadly superbugs.

Dr Aimee Murray, Research Fellow at the University of Exeter and GW4 Crucible 2020 Alumni explores how the COVID-19 crisis could impact AMR in clinical and community settings, and explains why GW4 is well placed to research and help combat these significant global challenges.

Antimicrobial resistance is predicted to be the leading cause of death globally by 2050 resulting in 10 million deaths per year, many caused by antibiotic resistant bacterial infections.
Choose which optional services may run. Necessary cookies used to make the website work are not affected.
Allows analytics tools to measure how the website is used.
Allows content from third-party services such as YouTube to load.